NO20020793L - Virkestoffkombinasjon med clonidin - Google Patents

Virkestoffkombinasjon med clonidin

Info

Publication number
NO20020793L
NO20020793L NO20020793A NO20020793A NO20020793L NO 20020793 L NO20020793 L NO 20020793L NO 20020793 A NO20020793 A NO 20020793A NO 20020793 A NO20020793 A NO 20020793A NO 20020793 L NO20020793 L NO 20020793L
Authority
NO
Norway
Prior art keywords
clonidine
active ingredient
ingredient combination
combination
pramipexole
Prior art date
Application number
NO20020793A
Other languages
English (en)
Other versions
NO20020793D0 (no
Inventor
Hans-Michael Brecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20020793D0 publication Critical patent/NO20020793D0/no
Publication of NO20020793L publication Critical patent/NO20020793L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen angår en kombinasjon aktive substanser. Denne kombinasjon består av clonidine og pramipexole for behandling av Restless Leg Syndrom.
NO20020793A 1999-08-19 2002-02-18 Virkestoffkombinasjon med clonidin NO20020793L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19938825A DE19938825A1 (de) 1999-08-19 1999-08-19 Wirkstoffkombination mit Clonidin
PCT/EP2000/007718 WO2001013902A2 (de) 1999-08-19 2000-08-09 Wirkstoffkombination enthaltend clonidin und pramipexol

Publications (2)

Publication Number Publication Date
NO20020793D0 NO20020793D0 (no) 2002-02-18
NO20020793L true NO20020793L (no) 2002-02-18

Family

ID=7918574

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020793A NO20020793L (no) 1999-08-19 2002-02-18 Virkestoffkombinasjon med clonidin

Country Status (19)

Country Link
US (1) US20020010201A1 (no)
EP (1) EP1210081A2 (no)
JP (1) JP2003507420A (no)
KR (1) KR20020060163A (no)
AR (1) AR025330A1 (no)
AU (1) AU6440600A (no)
BR (1) BR0013353A (no)
CA (1) CA2376606A1 (no)
CO (1) CO5200840A1 (no)
CZ (1) CZ2002515A3 (no)
DE (1) DE19938825A1 (no)
IL (1) IL147741A0 (no)
MX (1) MXPA02001138A (no)
NO (1) NO20020793L (no)
PE (1) PE20010642A1 (no)
PL (1) PL353358A1 (no)
TR (1) TR200200449T2 (no)
UY (1) UY26293A1 (no)
WO (1) WO2001013902A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
ES2432527T3 (es) 2001-12-11 2013-12-04 University Of Virginia Patent Foundation Uso de pramipexol para tratar la esclerosis lateral amiotrófica
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
CN1671390A (zh) 2002-08-30 2005-09-21 协和发酵工业株式会社 用于治疗多动腿综合症或相关疾病的腺苷a2a受体拮抗剂
EP1426049B1 (en) * 2002-12-02 2005-05-18 Schwarz Pharma Ag Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
DK2026803T3 (da) 2006-05-16 2012-04-16 Knopp Neurosciences Inc Sammensætninger af R(+) og S(-) pramipexol og fremgangsmåder til anvendelse heraf
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
AU2008224844B2 (en) 2007-03-14 2012-08-09 Knopp Neurosciences, Inc. Synthesis of chirally purified substituted benzothiazole diamines
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
CN102186350A (zh) 2008-08-19 2011-09-14 诺普神经科学股份有限公司 使用(r)-普拉克索的组合物与方法
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US20150342899A1 (en) * 2012-12-28 2015-12-03 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine and clonidine
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
ES2858500T3 (es) 2013-07-12 2021-09-30 Knopp Biosciences Llc Tratamiento de niveles elevados de eosinófilos y/o basófilos
AU2014306683B2 (en) 2013-08-13 2017-10-12 Knopp Biosciences Llc Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders
HUE055850T2 (hu) 2013-08-13 2022-01-28 Knopp Biosciences Llc Készítmények és módszerek a krónikus urticaria (csalánkiütés) kezelésére

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
DE4325491A1 (de) * 1993-07-29 1995-02-02 Boehringer Ingelheim Kg Verwendung von zentral wirksamen alpha-2-Agonisten zur Hemmung des Postaggressionsstoffwechsels
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19701619B4 (de) * 1997-01-17 2007-10-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Pramipexol zur Behandlung des restless legs syndroms
WO2000054773A1 (en) * 1999-03-12 2000-09-21 Nitromed, Inc. Dopamine agonists in combination with nitric oxide donors, compositions and methods of use

Also Published As

Publication number Publication date
AR025330A1 (es) 2002-11-20
PE20010642A1 (es) 2001-06-08
CZ2002515A3 (cs) 2002-05-15
NO20020793D0 (no) 2002-02-18
WO2001013902A2 (de) 2001-03-01
WO2001013902A3 (de) 2001-08-23
CA2376606A1 (en) 2001-03-01
JP2003507420A (ja) 2003-02-25
TR200200449T2 (tr) 2002-08-21
AU6440600A (en) 2001-03-19
US20020010201A1 (en) 2002-01-24
MXPA02001138A (es) 2002-10-31
DE19938825A1 (de) 2001-04-26
CO5200840A1 (es) 2002-09-27
IL147741A0 (en) 2002-08-14
PL353358A1 (en) 2003-11-17
EP1210081A2 (de) 2002-06-05
BR0013353A (pt) 2002-04-23
UY26293A1 (es) 2001-04-30
KR20020060163A (ko) 2002-07-16

Similar Documents

Publication Publication Date Title
NO20020793L (no) Virkestoffkombinasjon med clonidin
DE60109044D1 (de) Arzneimittel zur behandlung der mucositis, stomatitis und des behcetschen syndroms
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
IL147643A0 (en) Drug therapy of the restless leg syndrome
ID30062A (id) Alanog-analog benzopiran tersubstitusi untuk pengobatan radang
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
ATE305306T1 (de) Reboxetin zur behandlung von peripheren neuropathien
NO995932D0 (no) Anvendelse av tiazolidindion-derivater i behandling av polycystiske ovariesyndrom og svangerskapsdiabetes
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
ATE410426T1 (de) Heterocyclische verbindungen alsccr5-antagonisten
DE60136909D1 (de) Arzneimittel mit anemonin als aktivum zur behandlung von aseptischer inflammation
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
NO20040726L (no) Kombinasjonspreparater av arylsubstituerte propanolaminderivater med andre aktive forbindelser og anvendelse derav.
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
FI991616A (fi) Pramipeksolin käyttö levottomien jalkojen oireyhtymän hoidossa
AU3922900A (en) Use of (valeriana) for the treatment of restless leg syndrome and related disorders
ATE365038T1 (de) ARZNEIMITTEL ZUR BEHANDLUNG DES ßSYSTEMIC INFLAMMATORY RESPONSE SYNDROMEß
DE60043936D1 (de) Vorbeugung und behandlung von p. gingivalis infektion
DE50112512D1 (de) Phenanthridinderivate und phenanthridin enthaltende antitumorale arzneimittel
ES1043751Y (es) Tabla vibradora de efectos terapeuticos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application